These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9568732)

  • 1. Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Oshima R; Ikeda T; Watanabe K; Itakura H; Sugiyama N
    Atherosclerosis; 1998 Mar; 137(1):13-22. PubMed ID: 9568732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits.
    Daugherty A; Zweifel BS; Schonfeld G
    Br J Pharmacol; 1991 May; 103(1):1013-8. PubMed ID: 1878742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term probucol treatment reverses the severity of myocardial injury in watanabe heritable hyperlipidemic rabbits.
    Hoshida S; Yamashita N; Igarashi J; Aoki K; Kuzuya T; Hori M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2801-7. PubMed ID: 9409258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Murakami S; Kondo Y; Sakurai T; Kitajima H; Nagate T
    Atherosclerosis; 2002 Jul; 163(1):79-87. PubMed ID: 12048124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits.
    Andersen HO; Holm P; Nordestgaard BG; Hansen BF; Kjeldsen K; Elinder LS; Stender S
    J Mol Cell Cardiol; 1995 Aug; 27(8):1561-71. PubMed ID: 8523419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
    Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Ooshima A; Yoshida H; Kawai C
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5928-31. PubMed ID: 3475709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
    Lauridsen ST; Mortensen A
    Atherosclerosis; 1999 Jan; 142(1):169-78. PubMed ID: 9920518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit--long-term antiatherogenic effect and effects on established plaques.
    Nagano Y; Nakamura T; Matsuzawa Y; Cho M; Ueda Y; Kita T
    Atherosclerosis; 1992 Feb; 92(2-3):131-40. PubMed ID: 1632845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits.
    O'Brien K; Nagano Y; Gown A; Kita T; Chait A
    Arterioscler Thromb; 1991; 11(3):751-9. PubMed ID: 2029510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits.
    Kogushi M; Tanaka H; Ohtsuka I; Yamada T; Kobayashi H; Saeki T; Takada M; Hiyoshi H; Yanagimachi M; Kimura T; Yoshitake S; Saito I
    Atherosclerosis; 1996 Aug; 124(2):203-10. PubMed ID: 8830933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pharmacological doses of different antioxidants on oxidation parameters and atherogenesis in hyperlipidaemic rabbits.
    Djahansouzi S; Braesen JH; Koenig K; Beisiegel U; Kontush A
    Atherosclerosis; 2001 Feb; 154(2):387-98. PubMed ID: 11166771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of atherosclerotic progression in Watanabe rabbits by probucol.
    Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Narumiya S; Kawai C
    Am J Cardiol; 1988 Jul; 62(3):13B-19B. PubMed ID: 3394648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits.
    Niimi M; Keyamura Y; Nozako M; Koyama T; Kohashi M; Yasufuku R; Yoshikawa T; Fan J
    Lipids Health Dis; 2013 Nov; 12():166. PubMed ID: 24188322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of simvastatin on serum lipids and atherosclerosis in WHHL rabbits.
    Fukuo Y; Nagashima M; Saitoh A; Kobayashi Y; Terashi A; Nakama K; Kameyama K; Asano G
    Clin Ther; 1991; 13(3):417-24. PubMed ID: 1954642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo inhibition of foam cell development by probucol in Watanabe rabbits.
    Steinberg D; Parthasarathy S; Carew TE
    Am J Cardiol; 1988 Jul; 62(3):6B-12B. PubMed ID: 3394654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthocyanins increase low-density lipoprotein and plasma cholesterol and do not reduce atherosclerosis in Watanabe Heritable Hyperlipidemic rabbits.
    Finné Nielsen IL; Elbøl Rasmussen S; Mortensen A; Ravn-Haren G; Ma HP; Knuthsen P; Hansen BF; McPhail D; Freese R; Breinholt V; Frandsen H; Dragsted LO
    Mol Nutr Food Res; 2005 Apr; 49(4):301-8. PubMed ID: 15759306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits.
    Shiomi M; Ito T; Tsukada T; Yata T; Watanabe Y; Tsujita Y; Fukami M; Fukushige J; Hosokawa T; Tamura A
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1938-44. PubMed ID: 7583574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Kleinveld HA; Demacker PN; Stalenhoef AF
    Arterioscler Thromb; 1994 Aug; 14(8):1386-91. PubMed ID: 8049202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits.
    Yoshida N; Murase H; Kunieda T; Toyokuni S; Tanaka T; Terao J; Naito Y; Tanigawa T; Yoshikawa T
    Atherosclerosis; 2002 May; 162(1):111-7. PubMed ID: 11947904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of atherosclerosis using an antioxidant].
    Ishii K; Kita T
    Nihon Ronen Igakkai Zasshi; 1990 Mar; 27(2):177-81. PubMed ID: 2384991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.